Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION (MCK)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 01/23 10:03:50 pm
170.6 USD   -1.36%
08:32p New York City Sues Companies Over Opioid Abuse
08:04p New York City sues drug companies over opioid epidemic
01/22 MCKESSON : The Outlook for Health Care Business in 2018
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/17/2018 01/18/2018 01/19/2018 01/22/2018 01/23/2018 Date
172.83(c) 171.78(c) 170.36(c) 172.46(c) 170.6 Last
1 747 329 1 368 975 2 400 022 779 518 1 788 611 Volume
+1.27% -0.61% -0.83% +1.23% -1.36% Change
More quotes
Financials ($)
Sales 2018 206 B
EBIT 2018 3 662 M
Net income 2018 1 300 M
Debt 2018 4 431 M
Yield 2018 0,70%
Sales 2019 210 B
EBIT 2019 3 855 M
Net income 2019 2 159 M
Debt 2019 3 736 M
Yield 2019 0,75%
P/E ratio 2018 29,56
P/E ratio 2019 18,42
EV / Sales2018 0,20x
EV / Sales2019 0,19x
Capitalization 36 058 M
More Financials
Company
McKesson Corp. is a health services and information technology company, which provides medicines, pharmaceutical and care management products.It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions.The McKesson Distribution Solutions segment distributes... 
Sector
Drug Retailers
Calendar
02/01Earnings Release
More about the company
Surperformance© ratings of McKesson Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on MCKESSON CORPORATION
08:32p New York City Sues Companies Over Opioid Abuse
08:04p New York City sues drug companies over opioid epidemic
01/22 MCKESSON : The Outlook for Health Care Business in 2018
01/19 Delaware sues opioid manufacturers, distributors over epidemic
01/17 MCKESSON CORPORATION : - Vantage Cancer Care Network Collaborates with Alliance ..
01/17 MCKESSON : Rep. Bishop criticized for donations from opioid companies
01/17 MCKESSON : Ventures Donates $10,000 to Alzheimer's Association
01/16 MCKESSON : Five Digital Health Trends to Know
01/10 MCKESSON : Change in Directors or Principal Officers (form 8-K/A)
01/08 MCKESSON : Building Stronger Partnerships Between Independent Pharmacies and Pro..
More news
Sector news : Drug Retailers - NEC
08:32p New York City Sues Companies Over Opioid Abuse
08:04p New York City sues drug companies over opioid epidemic
01/22 DIXONS CARPHONE : enjoys strong Christmas before executive exodus
01/20 Dixons Carphone CEO James quits for job at Boots
01/19 Delaware sues opioid manufacturers, distributors over epidemic
More sector news : Drug Retailers - NEC
4-Traders Strategies on MCKESSON CORPORATION 
MCKESSON CORPORATION - 2012
An appropriate purchase level
BUY
MCKESSON CORPORATION - 2012
In oversold situation
BUY
More Strategies
Latest Tweets
01:39p$SLB $HAL $GS $TELL $JPM $WFC $BAC $C $TXN $ADI $NVDA $ADBE $AMZN $VMW $MSFT .. 
12:20pMcKesson $MCK PT Raised to $180 at Needham & Company  
05:00aLawsuit accuses drug distributor McKesson of fueling Kentucky's opioid epidem..
61
03:45a[email protected] Andy Beshear is suing McKesson Corporation, a national opioid distrib..
1
01:12aSuit accuses drug distributor McKesson of fueling Kentucky's opioid epidemic ..
2
More tweets
Qtime:127
News from SeekingAlpha
07:39a You Blink, You Miss - Cramer's Mad Money (1/22/18)
01/21 Top 10 Net Payout Yields For January 2018
01/14 BED PANS TO BARIATRIC CHAIRS : Owens & Minor Has It All
01/10 McKesson (MCK) Presents At 36th Annual J.P. Morgan Healthcare Conference - Sl..
01/08 Valuation Dashboard In Healthcare - New Year's Update
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 176 $
Spread / Average Target 1,8%
EPS Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
Britt Vitalone Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Marie L. Knowles Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION9.24%36 058
CVS HEALTH10.15%82 002
WALGREENS BOOTS ALLIANCE5.30%76 678
EXPRESS SCRIPTS HOLDING CO8.68%45 944
CARDINAL HEALTH17.37%23 172
AMERISOURCEBERGEN8.97%22 388